Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.

The review starts with a general outlook of the main mechanisms of action of antimicrobial proteins and peptides, with the final aim of understanding the biological function of antimicrobial RNases, and identifying the key events that account for their selective properties. Although most antibacterial proteins and peptides do display a wide-range spectrum of action, with a cytotoxic activity against bacteria, fungi, eukaryotic parasites and viruses, we have only focused on their bactericidal activity. We start with a detailed description of the main distinctive structural features of the bacteria target and on the polypeptides, which act as selective host defence weapons.Following, we include an overview of all the current available information on the mammalian RNases which display an antimicrobial activity. There is a wealth of information on the structural, catalytic mechanism and evolutionary relationships of the RNase A superfamily. The bovine pancreatic RNase A (RNase A), the reference member of the mammalian RNase family, has been the main research object of several Nobel laureates in the 60s, 70s and 80s. A potential antimicrobial function was only recently suggested for several members of this family. In fact, the recent evolutionary studies indicate that this protein family may have started off with a host defence function. Antimicrobial RNases constitute an interesting example of proteins involved in the mammalian innate immune defence system. Besides, there is wealth of available information on the mechanism of action of short antimicrobial peptides, but little is known on larger polypeptides, that is, on proteins. Therefore, the identification of the mechanisms of action of antimicrobial RNases would contribute to the understanding of the proteins involved in the innate immunity.

[1]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[2]  G. J. Swaminathan,et al.  Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN) , 2001, The Journal of Biological Chemistry.

[3]  J. Gabay,et al.  Ubiquitous natural antibiotics. , 1994, Science.

[4]  R. Larson,et al.  Specific mode of interaction between components of model pulmonary surfactants using computer simulations. , 2002, Journal of molecular biology.

[5]  Francis C. Neuhaus,et al.  A Continuum of Anionic Charge: Structures and Functions of d-Alanyl-Teichoic Acids in Gram-Positive Bacteria , 2003, Microbiology and Molecular Biology Reviews.

[6]  E. Hahn,et al.  Secretion and tissue content of eosinophil cationic protein in Crohn's disease. , 2000, Journal of clinical gastroenterology.

[7]  C. Deber,et al.  Anionic phospholipids modulate peptide insertion into membranes. , 1997, Biochemistry.

[8]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[9]  W. Fischer,et al.  Effect of lipoteichoic acid on thermotropic membrane properties , 1997, Journal of bacteriology.

[10]  Venge,et al.  Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  A. A. Bodegraven,et al.  Serum Eosinophil Cationic Protein in Active and Quiescent Ulcerative Colitis , 2000 .

[12]  J. Zhang,et al.  Sequence variation at two eosinophil-associated ribonuclease loci in humans. , 2000, Genetics.

[13]  G. Gleich Mechanisms of eosinophil-associated inflammation. , 2000, The Journal of allergy and clinical immunology.

[14]  E. Boix,et al.  The contribution of noncatalytic phosphate-binding subsites to the mechanism of bovine pancreatic ribonuclease A , 1998, Cellular and Molecular Life Sciences CMLS.

[15]  Jianzhi Zhang,et al.  Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. , 2003, Nucleic acids research.

[16]  R. Hancock,et al.  Cationic host defense (antimicrobial) peptides. , 2006, Current opinion in immunology.

[17]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[18]  G. Gleich,et al.  Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. , 2003, The Journal of allergy and clinical immunology.

[19]  Reto Stöcklin,et al.  Anti‐microbial peptides: from invertebrates to vertebrates , 2004, Immunological reviews.

[20]  T. Nürnberger,et al.  Innate immunity in plants and animals: emerging parallels between the recognition of general elicitors and pathogen-associated molecular patterns. , 2002, Current opinion in plant biology.

[21]  D. Andreu,et al.  Animal antimicrobial peptides: an overview. , 1998, Biopolymers.

[22]  H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[23]  Y. Shai,et al.  Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides , 2006, Journal of Biological Chemistry.

[24]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[25]  K. Dyer,et al.  The RNase a superfamily: Generation of diversity and innate host defense , 2006, Molecular Diversity.

[26]  M. Bertoldi,et al.  Structural versatility of bovine ribonuclease A. Distinct conformers of trimeric and tetrameric aggregates of the enzyme. , 1999, European journal of biochemistry.

[27]  E. Boix,et al.  Kinetic and Product Distribution Analysis of Human Eosinophil Cationic Protein Indicates a Subsite Arrangement That Favors Exonuclease-type Activity* , 1999, The Journal of Biological Chemistry.

[28]  T. Beveridge,et al.  Structural differentiation of the Bacillus subtilis 168 cell wall , 1994, Journal of bacteriology.

[29]  R. Prill,et al.  Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction , 1999, Nature Biotechnology.

[30]  D. Philpott,et al.  Mini‐review: The role of peptidoglycan recognition in innate immunity , 2004, European journal of immunology.

[31]  A. Ouellette,et al.  Activation of Paneth Cell α-Defensins in Mouse Small Intestine* , 2002, The Journal of Biological Chemistry.

[32]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[33]  M. Koch,et al.  Biophysical characterisation of lysozyme binding to LPS Re and lipid A. , 1998, European journal of biochemistry.

[34]  T. Pufe,et al.  Expression and regulation of antimicrobial peptides in articular joints. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[35]  L. Beamer Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins. , 2003, Biochemical Society transactions.

[36]  P. Jollès,et al.  What's new in lysozyme research? , 1984, Molecular and Cellular Biochemistry.

[37]  O. Levy,et al.  Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. , 2000, Blood.

[38]  Tomohiro Watanabe,et al.  Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.

[39]  C. Glabe Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.

[40]  D Eisenberg,et al.  Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. , 1997, Science.

[41]  R. Dziarski,et al.  Peptidoglycan recognition in innate immunity. , 2005, Journal of endotoxin research.

[42]  Y. Shai,et al.  Host defense peptides as new weapons in cancer treatment , 2005, Cellular and Molecular Life Sciences CMLS.

[43]  D Eisenberg,et al.  The BPI/LBP family of proteins: A structural analysis of conserved regions , 1998, Protein science : a publication of the Protein Society.

[44]  K. Dyer,et al.  Gene structure and enzymatic activity of mouse eosinophil-associated ribonuclease 2. , 2001, Gene.

[45]  K. Dyer,et al.  Evolution and Function of Leukocyte RNase A Ribonucleases of the Avian Species, Gallus gallus* , 2006, Journal of Biological Chemistry.

[46]  J. Heckels,et al.  Molecular arrangement of teichoic acid in the cell wall of Staphylococcus lactis. , 1973, Nature: New biology.

[47]  Susanna Navarro,et al.  Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. , 2007, Biochemistry.

[48]  K. Dyer,et al.  Rapid evolution of a unique family of primate ribonuclease genes , 1995, Nature Genetics.

[49]  M. V. Nogués,et al.  Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation , 2005, Molecular and Cellular Biochemistry.

[50]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[51]  J. Gavilanes,et al.  Bovine seminal ribonuclease destabilizes negatively charged membranes. , 1994, Biochemical and biophysical research communications.

[52]  H. Sticht,et al.  Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity , 2001, Protein science : a publication of the Protein Society.

[53]  Ziheng Yang,et al.  A Maximum Likelihood Method for Detecting Functional Divergence at Individual Codon Sites, with Application to Gene Family Evolution , 2004, Journal of Molecular Evolution.

[54]  Jianzhi Zhang,et al.  Rapid Evolution of the Ribonuclease A Superfamily: Adaptive Expansion of Independent Gene Clusters in Rats and Mice , 1999, Journal of Molecular Evolution.

[55]  S. Ehlers,et al.  Tertiary Structure of Bacterial Murein: the Scaffold Model , 2003, Journal of bacteriology.

[56]  S. Ehlers,et al.  Tertiary Structure of Staphylococcus aureus Cell Wall Murein , 2004, Journal of bacteriology.

[57]  Kai Hilpert,et al.  High-throughput generation of small antibacterial peptides with improved activity , 2005, Nature Biotechnology.

[58]  M. Nakajima,et al.  Expression and Purification of Recombinant Rat Eosinophil-Associated Ribonucleases, Homologues of Human Eosinophil Cationic Protein and Eosinophil-Derived Neurotoxin, and Their Characterization , 2001, International Archives of Allergy and Immunology.

[59]  K. Dyer,et al.  Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the ribonuclease A gene family. , 1997, Nucleic acids research.

[60]  R. Hancock,et al.  The relationship between peptide structure and antibacterial activity , 2003, Peptides.

[61]  C. Zipfel,et al.  Plants and animals: a different taste for microbes? , 2005, Current opinion in plant biology.

[62]  Robert E W Hancock,et al.  Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.

[63]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[64]  Klaus Düring,et al.  The non‐enzymatic microbicidal activity of lysozymes , 1999, FEBS letters.

[65]  F. G. Prendergast,et al.  Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: A mechanism for toxicity , 1992, The Journal of Membrane Biology.

[66]  J. Schröder,et al.  RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.

[67]  Chow H Lee,et al.  Destroying RNA as a therapeutic approach. , 2006, Current medicinal chemistry.

[68]  J. Schröder,et al.  Antimicrobial peptides in human skin. , 2005, Chemical immunology and allergy.

[69]  A. Glynn,et al.  Lysozyme and Immune Bacteriolysis , 1965, Nature.

[70]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[71]  S. Weinkauf,et al.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer. , 1999, Biophysical journal.

[72]  K. Fredens,et al.  Eosinophil Activation in Ulcerative Colitis (Studies on Mucosal Release and Localization of Eosinophil Granule Constituents) , 1998, Digestive Diseases and Sciences.

[73]  P. Venge,et al.  Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion , 1999, American Journal of Gastroenterology.

[74]  E. Boix,et al.  Crystal structure of eosinophil cationic protein at 2.4 A resolution. , 1999, Biochemistry.

[75]  P. Elsbach,et al.  Role of the bactericidal/permeability-increasing protein in host defence. , 1998, Current opinion in immunology.

[76]  D. Newton,et al.  Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. , 2001, Blood.

[77]  H. Rosenberg Recombinant Human Eosinophil Cationic Protein , 1995, The Journal of Biological Chemistry.

[78]  K. Ohuchi,et al.  Identification of cDNA for Rat Homologues of Human Major Basic Protein and Eosinophil Cationic Protein , 1998, International Archives of Allergy and Immunology.

[79]  G. H. Gudmundsson,et al.  Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.

[80]  J. Pous,et al.  Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. , 2000, Journal of molecular biology.

[81]  K. Diederichs,et al.  A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. , 2000, Structure.

[82]  Jonathan Cohen The immunopathogenesis of sepsis , 2002, Nature.

[83]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[84]  Jianzhi Zhang,et al.  Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[85]  James J. Lee,et al.  Mouse eosinophil-associated ribonucleases: a unique subfamily expressed during hematopoiesis , 2001, Mammalian Genome.

[86]  B. Niggemann,et al.  In vitro release of eosinophil cationic protein from peripheral eosinophils reflects disease activity in childhood Crohn disease and ulcerative colitis , 1997, European Journal of Pediatrics.

[87]  K. Dyer,et al.  Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. , 1997, Biochimica et biophysica acta.

[88]  P. Venge,et al.  Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.

[89]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[90]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[91]  D. Loegering,et al.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. , 1989, The American review of respiratory disease.

[92]  K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[93]  S. White,et al.  Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores , 1994, Protein science : a publication of the Protein Society.

[94]  S. Rybak,et al.  Humanization of immunotoxins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[95]  R. Dahl,et al.  Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[96]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[97]  D. Fischer,et al.  Detecting distant relatives of mammalian LPS‐binding and lipid transport proteins , 1998, Protein science : a publication of the Protein Society.

[98]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[99]  E. Boix,et al.  Eosinophil cationic protein. , 2001, Methods in enzymology.

[100]  Robert E. W. Hancock,et al.  Structure and Association of Human Lactoferrin Peptides with Escherichia coli Lipopolysaccharide , 2004, Antimicrobial Agents and Chemotherapy.

[101]  K. Diederichs,et al.  Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. , 1998, Science.

[102]  Jianzhi Zhang,et al.  The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. , 2005, Genomics.

[103]  M. Nakajima,et al.  Preparation of recombinant rat eosinophil-associated ribonuclease-1 and -2 and analysis of their biological activities. , 2003, Biochimica et biophysica acta.

[104]  Jianzhi Zhang,et al.  RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. , 2002, Nucleic acids research.

[105]  Niv Papo,et al.  Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? , 2003, Peptides.

[106]  J. Dubois,et al.  Molecular evolution of mammalian ribonucleases 1. , 2003, Molecular phylogenetics and evolution.

[107]  K. Acharya,et al.  Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. , 1999, Journal of molecular biology.

[108]  N. Krug,et al.  Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. , 2004, The Journal of allergy and clinical immunology.

[109]  D. Philpott,et al.  Recognition of Staphylococcus aureus by the Innate Immune System , 2005, Clinical Microbiology Reviews.

[110]  T. Koob,et al.  N- and O-Linked Keratan Sulfate on the Hyaluronan Binding Region of Aggrecan from Mature and Immature Bovine Cartilage (*) , 1995, The Journal of Biological Chemistry.

[111]  N. Pavlakis,et al.  Ranpirnase – an antitumour ribonuclease: its potential role in malignant mesothelioma , 2006, Expert opinion on biological therapy.

[112]  I. Hirata,et al.  Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[113]  J. Gesell,et al.  Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution , 1997, Journal of biomolecular NMR.

[114]  D. Eisenberg,et al.  Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. , 1996, Chemistry & biology.

[115]  D. Hughes,et al.  Sampling the Antibiotic Resistome , 2006, Science.

[116]  E. Pauwels,et al.  Human Lactoferrin and Peptides Derived from Its N Terminus Are Highly Effective against Infections with Antibiotic-Resistant Bacteria , 2001, Infection and Immunity.

[117]  S. Rybak,et al.  Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition , 2003, AIDS.

[118]  K. Ohuchi,et al.  Identification of cDNA encoding rat eosinophil cationic protein/eosinophil-associated ribonuclease. , 1997, Biochimica et biophysica acta.

[119]  Shih-Hsiung Wu,et al.  The Flexible and Clustered Lysine Residues of Human Ribonuclease 7 Are Critical for Membrane Permeability and Antimicrobial Activity* , 2007, Journal of Biological Chemistry.

[120]  M Ptak,et al.  Refined three-dimensional solution structure of insect defensin A. , 1995, Structure.

[121]  S. Verselis,et al.  Angiogenin is regulated in vivo as an acute phase protein. , 1998, Biochemical and biophysical research communications.

[122]  K. Dyer,et al.  Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. , 1998, Nucleic acids research.

[123]  D. Sidransky,et al.  Ribonucleases as a Novel Pro-Apoptotic Anticancer Strategy: Review of the Preclinical and Clinical Data for Ranpirnase , 2005, Cancer investigation.

[124]  Y. Raab,et al.  A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease , 2002, American Journal of Gastroenterology.

[125]  K. Amako,et al.  Distribution of capsular materials on the cell wall surface of strain Smith diffuse of Staphylococcus aureus , 1991, Journal of bacteriology.

[126]  R. Ellison,et al.  Killing of gram-negative bacteria by lactoferrin and lysozyme. , 1991, The Journal of clinical investigation.

[127]  T. Yip,et al.  Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. , 1998, Biochimica et biophysica acta.

[128]  M. Moenner,et al.  The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. , 1994, European journal of biochemistry.

[129]  S. Blondelle,et al.  Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. , 2005, Combinatorial chemistry & high throughput screening.

[130]  K. Dyer,et al.  Eosinophil Cationic Protein and Eosinophil-derived Neurotoxin , 1995, Journal of Biological Chemistry.

[131]  I. Ginsburg Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. , 2004, Medical hypotheses.

[132]  M. Caroff,et al.  Structure of bacterial lipopolysaccharides. , 2003, Carbohydrate research.

[133]  Ester Boix,et al.  Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. , 2003, Biochemistry.

[134]  I. Autenrieth,et al.  Intestinal epithelial barrier and mucosal immunity , 2005, Cellular and Molecular Life Sciences.

[135]  G. Gotte,et al.  Thermal Aggregation of Ribonuclease A , 2003, The Journal of Biological Chemistry.

[136]  J. Gabay,et al.  Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. , 1993, Current opinion in immunology.

[137]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[138]  D. Eisenberg,et al.  The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. , 1999, Biochemical pharmacology.